SCHEMBL15959747

SCHEMBL15959747

Cc1ccc2c(c1)c1ccccc1c1cc3c(cc21)sc1cc2c4ccc(OS(=O)(=O)C(F)(F)F)cc4c4ccccc4c2cc13

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ PTPN7 P35236 1/20 0.38
▸ DUSP3 P51452 1/20 0.38
▸ PTPN12 Q05209 1/20 0.38
▸ PTPN22 Q9Y2R2 1/20 0.38
▸ HTR1A P08908 4/20 0.36
▸ HTR1D P28221 4/20 0.36
▸ HTR1B P28222 4/20 0.36
▸ CHRM1 P11229 4/20 0.36
▸ DRD2 P14416 3/20 0.36
▸ DRD4 P21917 3/20 0.36
▸ DRD3 P35462 3/20 0.36
▸ HTR2C P28335 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15952958 0.92 CA1 (0.44) CA1CA2PTPN7DUSP3PTPN12
SCHEMBL10023269 0.90 HTR1A (0.41) CA1CA2HTR1AHTR1DHTR1B
SCHEMBL17552366 0.90 HTR1A (0.41) CA1CA2HTR1AHTR1DHTR1B
SCHEMBL15096687 0.90 HTR1A (0.41) CA1CA2HTR1AHTR1DHTR1B
SCHEMBL21824195 0.89 PTPN7 (0.46) CA1CA2PTPN7DUSP3PTPN12
SCHEMBL29813826 0.89 PTPN7 (0.46) CA1CA2PTPN7DUSP3PTPN12
SCHEMBL29511664 0.81 HTR1D (0.47) CA1CA2HTR1AHTR1DHTR1B
SCHEMBL2810467 0.81 HTR1D (0.47) CA1CA2HTR1AHTR1DHTR1B
SCHEMBL1702438 0.81 HTR1D (0.47) CA1CA2HTR1AHTR1DHTR1B
SCHEMBL10023272 0.81 HTR1D (0.47) CA1CA2HTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160204345-A1 DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2016-07-14 — — US disclosed
US-9166177-B2 Ditriphenylene derivative and organic electroluminescent device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2015-10-20 — — US disclosed
US-20140231754-A1 DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Yen, Feng-wen (TW) 2014-08-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160204345-A1 DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NR2E1, NR0B1, NR2E3 CA1 3730/4885CA2 3267/4885PTPN7 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback